Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | ELANE | P08246 | 2/20 | 0.46 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 4/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 3/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.40 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.40 |
| ▸ | RELA | Q04206 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26321816 | 0.83 | ALDH1A1 (0.50) | ALDH1A1ELANETRPA1HPGDKDM4E | |
| SCHEMBL10682793 | 0.82 | MEN1 (0.47) | ALDH1A1HPGDKDM4EHSD17B10TP53 | |
| SCHEMBL9222854 | 0.78 | TRPA1 (0.46) | ALDH1A1ELANETRPA1HPGDKDM4E | |
| SCHEMBL2534631 | 0.78 | ALDH1A1 (0.47) | ALDH1A1ELANEHPGDKDM4EHSD17B10 | |
| SCHEMBL2532344 | 0.78 | GABRA1 (0.47) | ALDH1A1ELANETRPA1HPGDTP53 | |
| SCHEMBL4265966 | 0.76 | PDK2 (0.44) | ALDH1A1ELANETRPA1HPGDKDM4E | |
| SCHEMBL673891 | 0.76 | ALDH1A1 (0.62) | ALDH1A1ELANETRPA1HPGDKDM4E | |
| SCHEMBL4743302 | 0.76 | ALDH1A1 (0.42) | ALDH1A1ELANETRPA1HPGDKDM4E | |
| SCHEMBL9742287 | 0.76 | MCL1 (0.50) | ALDH1A1ELANEHPGDKDM4EHSD17B10 | |
| SCHEMBL23367880 | 0.74 | MAP2 (0.43) | ALDH1A1HPGDKDM4EHSD17B10RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150329452-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE ISOPULEGOL AND OPTICALLY ACTIVE MENTHOL | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2015-11-19 | — | — | US | disclosed |
| EP-2921228-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE ISOPULEGOL AND OPTICALLY ACTIVE MENTHOL | Takasago International Corporation (JP) | 2015-09-23 | — | — | EP | disclosed |
| US-9061959-B2 | Method for manufacturing optically active menthol | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2015-06-23 | — | — | US | disclosed |
| EP-2647616-A1 | METHOD FOR MANUFACTURING OPTICALLY ACTIVE MENTHOL | Takasago International Corporation (JP) | 2013-10-09 | — | — | EP | disclosed |
| US-20130253228-A1 | METHOD FOR MANUFACTURING OPTICALLY ACTIVE MENTHOL | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2013-09-26 | — | — | US | disclosed |
| US-8329931-B2 | Organoaluminum compound | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2012-12-11 | — | — | US | disclosed |
| US-20110295031-A1 | ORGANOALUMINUM COMPOUND | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2011-12-01 | — | — | US | disclosed |
| EP-2390001-A1 | Organoaluminium compounds and their use as catalysts in the selective cyclisation of citronellal to isopulegol | Takasago International Corporation (JP) | 2011-11-30 | — | — | EP | disclosed |
| US-20110256013-A1 | METHOD FOR PRODUCING REGENERATED TARGET | TANAKA HOLDINGS CO., LTD. (JP) | 2011-10-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150329452-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE ISOPULEGOL AND OPTICALLY ACTIVE MENTHOL | ACSL3, ACSL6, ALOX5 | ALDH1A1 484/4885ELANE 3707/4885TRPA1 69/4885 |
| US-20110295031-A1 | ORGANOALUMINUM COMPOUND | CDC5L, ACSL3, MSMO1 | ALDH1A1 1124/4885ELANE 3077/4885TRPA1 73/4885 |
| US-20130253228-A1 | METHOD FOR MANUFACTURING OPTICALLY ACTIVE MENTHOL | MSMO1, GGPS1, MAN1B1 | ALDH1A1 79/4885ELANE 2246/4885TRPA1 267/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.